Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02882373
What this trial is testing

Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury

Who this might be right for
Drug-Induced NephropathyHypertensionProteinuria
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01016873
What this trial is testing

INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD

Who this might be right for
AMDWet AMDAge-Related Macular Degeneration+4 more
Oraya Therapeutics, Inc. 230
Testing effectiveness (Phase 2)Study completedNCT04626128
What this trial is testing

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Clearside Biomedical, Inc. 27
Not applicableStudy completedNCT05791695
What this trial is testing

The Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022

Who this might be right for
Intraocular InflammationSuspected Endophthalmitis
Regeneron Pharmaceuticals 155,413
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Study completedNCT00022048
What this trial is testing

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Stanford University
Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Early research (Phase 1)Ended earlyNCT00426829
What this trial is testing

Proton Therapy and Bevacizumab for Primary Liver Tumors

Who this might be right for
Liver CancerHepatocellular CarcinomaCholangiocarcinoma
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT02015351
What this trial is testing

Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study

Who this might be right for
Choroidal Neovascularization
University of Sao Paulo 9
Testing effectiveness (Phase 2)Looking for participantsNCT06517888
What this trial is testing

Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma

Who this might be right for
Vestibular Schwannoma
Akouos, Inc. 27
Large-scale testing (Phase 3)WithdrawnNCT04697953
What this trial is testing

Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals
Not applicableStudy completedNCT00897754
What this trial is testing

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 200
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01213082
What this trial is testing

ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)

Who this might be right for
Exudative Age-related Macular Degeneration
University of California, Davis 34
Not applicableUnknownNCT01310686
What this trial is testing

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Wet AMD
West Coast Retina Medical Group, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT00023920
What this trial is testing

Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive
National Cancer Institute (NCI) 60
Not applicableStudy completedNCT02452840
What this trial is testing

Photodynamic Therapy for PDA in NV AMD

Who this might be right for
Neovascular Age-related Macular DegenerationMacular Degeneration
Duke University 100
Testing effectiveness (Phase 2)Study completedNCT01610557
What this trial is testing

Ranibizumab and Bevacizumab for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
National Eye Institute (NEI) 56
Testing effectiveness (Phase 2)Study completedNCT00113230
What this trial is testing

Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer

Who this might be right for
Rectal Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00015951
What this trial is testing

Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaMyelodysplastic Syndromes
University of Maryland, Baltimore
Next Page